expert.ai Insight Engine for Life Sciences
Having timely access to relevant data accelerates decision making, reduces regulatory review cycles and helps bring better medical treatments to market faster. Leveraging artificial intelligence helps biomedical researchers monitor trends, protect IP, discover new drugs and track key experts as they collaborate using the most current knowledge about diagnosis, treatment and prevention.
Enhance Pharma Insights and Protection with AI Analysis
From innovation to regulation to patient engagement, we help life science and pharmaceutical organizations to gain the the most insights from all their information assets to improve R&D productivity, enhance the quality of treatment and care and prevent operational risks.
Expert.ai’s Life Science and Pharmaceutical solutions provides research, regulatory and knowledge teams with capabilities like:
- Access to real-time data sources (public, subscription-based or private) under a unified semantic schema and taxonomy for specific therapies.
- The ability to automatically analyze and validate specific scientific claims to see if they are confirmed, or not, against a set of trusted sources.
- Customizable search results and dashboards that compare trusted life sciences resources with domain- specific Knowledge Graphs to identify new, relevant and valuable information for drug discovery.
12M+
Key Opinion Leaders
450k+
UMLS Drugs and Interventions
100k+
UMLS Diseases
6M+
Relationships
Life Science & Pharma Solution Areas
Drug Discovery
Automatically extract connections between biomedical entities in literature for in-depth causality analysis in support to researchers.
Clinical Trial Insights
Monitor clinical trials and social media sources filtered by any combination of indication, drug, mechanism of action, sponsor or geography gain clinical trial insights.
Scientific Publication Insight & Analysis
Scan the latest scientific and biopharma news on drug approvals, trials, conferences and more to ensure users get instant updates for their topics of interest.
Regulatory Report Quality Reviews
Accelerate the quality control check processes of preclinical reports prior to their submission to regulatory bodies.
Intellectual Property Protection
Review patent claims against claims in published papers and clinical trial activity automatically alerting to potential areas of infringement and/or licensing opportunities.
